These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 20233360)
1. Quality of methylene-blue-treated fresh-frozen plasma stored up to 27 months. Moog R; Reichenberg S; Hoburg A; Müller N Transfusion; 2010 Feb; 50(2):516-8. PubMed ID: 20233360 [No Abstract] [Full Text] [Related]
2. Quantitative and qualitative analysis of proteins in fresh frozen plasma obtained from whole blood donations and prepared with two photochemical treatments. Cid J; Ramiro L; Martínez N; Palomo M; Magallon O; Claparols M; Ortiz P; Puig L; Pla RP Transfus Apher Sci; 2008 Oct; 39(2):115-21. PubMed ID: 18710822 [TBL] [Abstract][Full Text] [Related]
3. Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C. Ettinger A; Miklauz MM; Hendrix BK; Bihm DJ; Maldonado-Codina G; Goodrich RP Transfus Apher Sci; 2011 Feb; 44(1):25-31. PubMed ID: 21251884 [TBL] [Abstract][Full Text] [Related]
4. Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants. Aznar JA; Bonanad S; Montoro JM; Hurtado C; Cid AR; Soler MA; De Miguel A Vox Sang; 2000; 79(3):156-60. PubMed ID: 11111234 [TBL] [Abstract][Full Text] [Related]
5. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen. Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283 [TBL] [Abstract][Full Text] [Related]
6. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma. Smith J; Rock G Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060 [TBL] [Abstract][Full Text] [Related]
7. Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation. Thiele T; Kellner S; Hron G; Wasner C; Nauck M; Zimmermann K; Wessel A; Warkentin TE; Greinacher A; Selleng K Transfusion; 2012 Mar; 52(3):529-36. PubMed ID: 21880044 [TBL] [Abstract][Full Text] [Related]
8. Virus inactivation in blood components by photoactive phenothiazine dyes. Wagner SJ Transfus Med Rev; 2002 Jan; 16(1):61-6. PubMed ID: 11788930 [TBL] [Abstract][Full Text] [Related]
9. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C. Bihm DJ; Ettinger A; Buytaert-Hoefen KA; Hendrix BK; Maldonado-Codina G; Rock G; Giclas PC; Goodrich RP Vox Sang; 2010 Feb; 98(2):108-15. PubMed ID: 19719460 [TBL] [Abstract][Full Text] [Related]
10. The effect of methylene blue photoinactivation and methylene blue removal on the quality of fresh-frozen plasma. Garwood M; Cardigan RA; Drummond O; Hornsey VS; Turner CP; Young D; Williamson LM; Prowse CV Transfusion; 2003 Sep; 43(9):1238-47. PubMed ID: 12919426 [TBL] [Abstract][Full Text] [Related]
11. Plasma temperature during methylene blue/light treatment influences virus inactivation capacity and product quality. Gravemann U; Handke W; Sumian C; Alvarez I; Reichenberg S; Müller TH; Seltsam A Vox Sang; 2018 May; 113(4):368-377. PubMed ID: 29484670 [TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation of plasma after methylene blue and white light treatment in four Chinese blood centers. Chunhui Y; Guohui B; Hong Y; Xiaopu X; Zherong B; Mingyuan W; Xinsheng Z; Juanjuan W; Changqing L; Wuping L Transfus Apher Sci; 2013 Dec; 49(3):631-9. PubMed ID: 23928128 [TBL] [Abstract][Full Text] [Related]
13. Factors affecting virus photoinactivation by a series of phenothiazine dyes. Wagner SJ; Skripchenko A; Robinette D; Foley JW; Cincotta L Photochem Photobiol; 1998 Mar; 67(3):343-9. PubMed ID: 9523534 [TBL] [Abstract][Full Text] [Related]
14. The effect of pathogen inactivation on cryoprecipitate: a functional and quantitative evaluation. Kamyszek RW; Foster MW; Evans BA; Stoner K; Poisson J; Srinivasan AJ; Thompson JW; Moseley MA; Mooberry MJ; Welsby IJ Blood Transfus; 2020 Nov; 18(6):454-464. PubMed ID: 33000752 [TBL] [Abstract][Full Text] [Related]
15. A biochemical comparison of a pharmaceutically licensed coagulation active plasma (Octaplas) with a universally applicable development product (Uniplas) and single-donor FFPs subjected to methylene-blue dye and white-light treatment. Heger A; Römisch J; Svae TE Transfus Apher Sci; 2006 Dec; 35(3):223-33. PubMed ID: 17118709 [TBL] [Abstract][Full Text] [Related]
16. Thrombin generation, ProC(®)Global, prothrombin time and activated partial thromboplastin time in thawed plasma stored for seven days and after methylene blue/light pathogen inactivation. Thiele T; Hron G; Kellner S; Wasner C; Westphal A; Warkentin TE; Greinacher A; Selleng K Blood Transfus; 2016 Jan; 14(1):66-72. PubMed ID: 26192785 [TBL] [Abstract][Full Text] [Related]